These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31594096)

  • 21. Noradrenaline as an alternative medical treatment to terlipressin in the management of hepatorenal syndrome type 1.
    Sendra C; Silva Ruiz MDP; Ferrer Rios MT; Alarcón García JC; Pascasio Acevedo JM
    Gastroenterol Hepatol; 2018; 41(7):440-441. PubMed ID: 29054321
    [No Abstract]   [Full Text] [Related]  

  • 22. Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: A randomized controlled study.
    Saif RU; Dar HA; Sofi SM; Andrabi MS; Javid G; Zargar SA
    Indian J Gastroenterol; 2018 Sep; 37(5):424-429. PubMed ID: 30178092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis.
    Rodríguez E; Elia C; Solà E; Barreto R; Graupera I; Andrealli A; Pereira G; Poca M; Sánchez J; Guevara M; Soriano G; Alessandria C; Fernández J; Arroyo V; Ginès P
    J Hepatol; 2014 May; 60(5):955-61. PubMed ID: 24447876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological Therapies for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis.
    Nanda A; Reddy R; Safraz H; Salameh H; Singal AK
    J Clin Gastroenterol; 2018 Apr; 52(4):360-367. PubMed ID: 28991106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terlipressin and albumin combination treatment in hepatorenal syndrome.
    Danalioglu A; Cakaloglu Y; Karaca C; Aksoy N; Akyuz F; Ozdil S; Demir K; Besisik F; Boztas G; Mungan Z; Kaymakoglu S; Okten A
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccciii-cccv. PubMed ID: 15244209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.
    Jiang QQ; Han MF; Ma K; Chen G; Wan XY; Kilonzo SB; Wu WY; Wang YL; You J; Ning Q
    World J Gastroenterol; 2018 Jun; 24(21):2300-2310. PubMed ID: 29881239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Terlipressin: Leading the Water to the Thirsty.
    Nanchal RS; Warrillow S
    Crit Care Med; 2022 Oct; 50(10):1533-1535. PubMed ID: 36106971
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute Kidney Injury in Cirrhosis.
    Karvellas CJ; Durand F; Nadim MK
    Crit Care Clin; 2015 Oct; 31(4):737-50. PubMed ID: 26410141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terlipressin use in HRS-AKI and respiratory failure. Author's reply.
    Nadim MK; Forni LG; Ostermann M;
    Intensive Care Med; 2024 Oct; 50(10):1713-1714. PubMed ID: 39133282
    [No Abstract]   [Full Text] [Related]  

  • 30. High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome.
    Hinz M; Wree A; Jochum C; Bechmann LP; Saner F; Gerbes AL; Gerken G; Canbay A
    Ann Hepatol; 2013; 12(1):92-9. PubMed ID: 23293199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current indications for the use of albumin in the treatment of cirrhosis.
    Alves de Mattos A
    Ann Hepatol; 2011 May; 10 Suppl 1():S15-20. PubMed ID: 21566250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure.
    Jindal A; Bhadoria AS; Maiwall R; Sarin SK
    Liver Int; 2016 Jan; 36(1):59-67. PubMed ID: 26081914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: A randomized controlled trial.
    Kandil MA; Abouelenain KM; Alsebaey A; Rashed HS; Afifi MH; Mahmoud MA; Yassen KA
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28564127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Physiopathological bases for the use of human albumin in liver cirrhosis].
    Arroyo V; Fernández J
    Gastroenterol Hepatol; 2012 Jan; 35(1):42-9. PubMed ID: 21944230
    [No Abstract]   [Full Text] [Related]  

  • 36. [Circulatory support with albumin in liver cirrhosis].
    Arroyo V; Terra C; Torre A
    Gastroenterol Hepatol; 2005 Feb; 28(2):74-9. PubMed ID: 15710087
    [No Abstract]   [Full Text] [Related]  

  • 37. Human albumin in the management of complications of liver cirrhosis.
    Bernardi M; Maggioli C; Zaccherini G
    Crit Care; 2012 Dec; 16(2):211. PubMed ID: 22429536
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of albumin in the treatment of cirrhosis: introduction.
    Terg R
    Ann Hepatol; 2011 May; 10 Suppl 1():S5. PubMed ID: 21566248
    [No Abstract]   [Full Text] [Related]  

  • 39. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.
    Ortega R; Ginès P; Uriz J; Cárdenas A; Calahorra B; De Las Heras D; Guevara M; Bataller R; Jiménez W; Arroyo V; Rodés J
    Hepatology; 2002 Oct; 36(4 Pt 1):941-8. PubMed ID: 12297842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient.
    Ibrisim D; Cakaloglu Y; Akyuz F; Karadag A; Ozdil S; Besisik F; Mungan Z; Okten A
    Scand J Gastroenterol; 2006 Jul; 41(7):862-5. PubMed ID: 16785202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.